FSD Pharma Submits a Phase-1b Clinical Trial Application for Ethics Committee for its Proprietary Beverage unbuzzd(TM) [Yahoo! Finance]
FSD Pharma Inc. - Class B Subordinate Voting Shares (HUGE)
Company Research
Source: Yahoo! Finance
company dedicated to building a portfolio of innovative assets and biotech solutions to address ailments affecting millions worldwide, today announces the submission of the Company's Clinical Trial Application (CTA) for a planned Phase-1b clinical trial to Assess the Safety and Efficacy of unbuzzd™ in Healthy Volunteers in an Induced State of Alcohol Intoxication (METAL-1 TRIAL). This clinical trial application is submitted for review by a human ethics review committee ("HREC") in Australia, a first step to obtain permission to initiate the clinical trial. Recruitment of healthy volunteers to this trial is expected to begin this April, following approval by the HREC. unbuzzd™ is the dietary supplement product under development for potential marketing in the United States. unbuzzd™ is a fortified oral liquid formula with natural ingredients, vitamins and other food supplements that potentially enhances cognition, replenishes cofactors needed for alcohol metabolism, and has the shown
Show less
Read more
Impact Snapshot
Event Time:
HUGE
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
HUGE alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
HUGE alerts
High impacting FSD Pharma Inc. - Class B Subordinate Voting Shares news events
Weekly update
A roundup of the hottest topics
HUGE
News
- FSD Pharma Provides Update from Celly Nu’s Partnership with Six+One for unbuzzd(TM)Accesswire
- FSD Pharma Provides Another Update on Celly Nu's Anticipated Launch of unbuzzd(TM) [Yahoo! Finance]Yahoo! Finance
- FSD Pharma Provides Another Update on Celly Nu's Anticipated Launch of unbuzzd(TM)Accesswire
- FSD Pharma Expands Investigative Pipeline to Include Potential Weight Loss and Liver Health Formulations and Products [Yahoo! Finance]Yahoo! Finance
- FSD Pharma Expands Investigative Pipeline to Include Potential Weight Loss and Liver Health Formulations and ProductsAccesswire
HUGE
Sec Filings
- 4/25/24 - Form 6-K
- 4/22/24 - Form 6-K
- 4/17/24 - Form 6-K
- HUGE's page on the SEC website